Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Reexamining the emperor's new clothes: ambiguities in current cardiac screening recommendations for youth with attention deficit hyperactivity disorder.

Leslie LK, Alexander ME, Trikalinos TA, Cohen JT, Parsons SK, Newburger JW.

Circ Cardiovasc Qual Outcomes. 2008 Nov;1(2):134-7. doi: 10.1161/CIRCOUTCOMES.108.825232. No abstract available.

2.

Cardiovascular safety of medication treatments for attention-deficit/hyperactivity disorder.

Newcorn JH, Donnelly C.

Mt Sinai J Med. 2009 Apr;76(2):198-203. doi: 10.1002/msj.20096. No abstract available.

PMID:
19306385
3.

ECGs before stimulants in children.

[No authors listed]

Med Lett Drugs Ther. 2008 Jul 28;50(1291):60. No abstract available.

PMID:
18654112
4.

Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder.

Perrin JM, Friedman RA, Knilans TK; Black Box Working Group; Section on Cardiology and Cardiac Surgery.

Pediatrics. 2008 Aug;122(2):451-3. doi: 10.1542/peds.2008-1573. No abstract available.

PMID:
18676566
5.

Cardiovascular monitoring of children and adolescents with heart disease receiving medications for attention deficit/hyperactivity disorder [corrected]: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing.

Vetter VL, Elia J, Erickson C, Berger S, Blum N, Uzark K, Webb CL; American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee; American Heart Association Council on Cardiovascular Nursing.

Circulation. 2008 May 6;117(18):2407-23. doi: 10.1161/CIRCULATIONAHA.107.189473. Epub 2008 Apr 21. No abstract available. Erratum in: Circulation. 2009 Aug 18;120(7):e55-9.

6.

Stimulants and sudden death: what is a physician to do?

Wilens TE, Prince JB, Spencer TJ, Biederman J.

Pediatrics. 2006 Sep;118(3):1215-9. Review.

PMID:
16951018
7.
8.

[Attention deficit hyperkinetic syndrome (ADHS) and stimulants].

Rothenberger A.

Z Kinder Jugendpsychiatr Psychother. 2002 Aug;30(3):159-61. German. No abstract available.

PMID:
12227218
9.
10.

[Medication for ADHD and the risk of cardiovascular mortality].

Kalverdijk LJ, Buitelaar JK, van der Gaag RJ.

Ned Tijdschr Geneeskd. 2006 Oct 14;150(41):2283-4; author reply 2284. Dutch. No abstract available.

PMID:
17078147
11.

[Treatment with central nervous system stimulants. Practical guidelines].

Hvolby A, Jørgensen JI.

Ugeskr Laeger. 2004 Jan 12;166(3):144-8. Danish. No abstract available.

PMID:
14870640
12.

. . . and recommending an ECG starting stimulant medicines in kids.

[No authors listed]

Child Health Alert. 2008 Sep;26:2-3. No abstract available.

PMID:
18953696
13.

Cardiovascular considerations of attention deficit hyperactivity disorder medications: a report of the European Network on Hyperactivity Disorders work group, European Attention Deficit Hyperactivity Disorder Guidelines Group on attention deficit hyperactivity disorder drug safety meeting.

Hamilton RM, Rosenthal E, Hulpke-Wette M, Graham JG, Sergeant J; European Network of Hyperkinetic Disorders.

Cardiol Young. 2012 Feb;22(1):63-70. doi: 10.1017/S1047951111000928. Epub 2011 Jul 19. Erratum in: Cardiol Young. 2012 Feb;22(1):120.

PMID:
21771383
15.

Cardiac safety of central nervous system stimulants in children and adolescents with attention-deficit/hyperactivity disorder.

Winterstein AG, Gerhard T, Shuster J, Johnson M, Zito JM, Saidi A.

Pediatrics. 2007 Dec;120(6):e1494-501.

PMID:
18055666
16.

Electrocardiograms for attention deficit disorder.

Moodie DS.

Congenit Heart Dis. 2008 Sep-Oct;3(5):307. doi: 10.1111/j.1747-0803.2008.00211.x. No abstract available.

PMID:
18837807
17.

Psychotherapeutic medication patterns for youths with attention-deficit/hyperactivity disorder.

Zito JM, Safer DJ, dosReis S, Magder LS, Gardner JF, Zarin DA.

Arch Pediatr Adolesc Med. 1999 Dec;153(12):1257-63.

PMID:
10591302
18.

[Treatment with central nervous system stimulants].

Zlotnik G.

Ugeskr Laeger. 2004 Mar 1;166(10):925; author reply 925. Danish. No abstract available.

PMID:
15045741
19.

Cardiovascular safety of ADHD medication treatments.

Newcorn JH.

CNS Spectr. 2008 Oct;13(10 Suppl 15):5-8. No abstract available.

PMID:
18955948
20.

Summary of the practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults.

Greenhill LL, Pliszka S, Dulcan MK, Bernet W, Arnold V, Beitchman J, Benson RS, Bukstein O, Kinlan J, McClellan J, Rue D, Shaw JA, Stock S, Kroeger K.

J Am Acad Child Adolesc Psychiatry. 2001 Nov;40(11):1352-5.

PMID:
11699811

Supplemental Content

Support Center